Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALStandard

FABIOR

TAZAROTENE

Standard Dose
0.1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview FABIOR is listed in Drugs@FDA under application 202428 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TAZAROTENE Form and strength AEROSOL, FOAM;TOPICAL - 0.1% Sponsor MAYNE PHARMA Submission history Latest submission status date: 2012-05-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview FABIOR is listed in Drugs@FDA under application 202428 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TAZAROTENE Form and strength AEROSOL, FOAM;TOPICAL - 0.1% Sponsor MAYNE PHARMA Submission history Latest submission status date: 2012-05-11 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.